• Profile
Close

Effect of apolipoprotein E ?4 carrier status on cognitive response to acetylcholinesterase inhibitors in patients with Alzheimer’s disease: A systematic review and meta-analysis

Dementia and Geriatric Cognitive Disorders Jul 27, 2018

Cheng YC, et al. - Researchers explored the link between treatment response with acetylcholinesterase inhibitors (AChEIs) and the apolipoprotein E ?4 (APOE ?4) carrier status through a systematic review and meta-analysis. They involved clinical studies with Alzheimer’s disease (AD) patients reporting APOE ?4 genotype in this analysis. In patients with AD, APOE ?4 carrier status had no considerable impact on the treatment response to AChEIs. Compared with placebo, irrespective of APOE ?4 carrier status, AChEIs had a positive therapeutic effect.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay